Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder

Rebecca MacGregor Legge, Shahbaz Sendi, James H. Cole, Sarah Cohen-Woods, Sergi G. Costafreda, Andrew Simmons, Anne E. Farmer, Katherine J. Aitchison, Peter McGuffin, Cynthia H. Y. Fu

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Abstract

Background: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism contributes to the development of depression (major depressive disorder, MDD), but it is unclear whether neural effects observed in healthy individuals are sustained in MDD. Aims: To investigate BDNF Val66Met effects on key regions in MDD neurocircuitry: amygdala, anterior cingulate, middle frontal and orbitofrontal regions. Method: Magnetic resonance imaging scans were acquired in 79 persons with MDD (mean age 49 years) and 74 healthy volunteers (mean age 50 years). Effects on surface area and cortical thickness were examined with multiple comparison correction. Results: People who were Met allele carriers showed reduced caudal middle frontal thickness in both study groups. Significant interaction effects were found in the anterior cingulate and rostral middle frontal regions, in which participants in the MDD group who were Met carriers showed the greatest reduction in surface area. Conclusions: Modulatory effects of the BDNF Val66Met polymorphism on distinct subregions in the prefrontal cortex in MDD support the neurotrophin model of depression.

Original languageEnglish
Pages (from-to)379-384
Number of pages6
JournalBritish Journal of Psychiatry
Volume206
Issue number5
DOIs
Publication statusPublished - May 2015
Externally publishedYes

Fingerprint Dive into the research topics of 'Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder'. Together they form a unique fingerprint.

Cite this